Current status of cancer immunotherapy for gynecologic malignancies

Abstract Recent cancer immunotherapy development with immune checkpoint inhibitors has shown durable clinical responses in a wide variety of tumor types. These drugs targeting programmed cell death 1, its ligand programmed death ligand 1 and cytotoxic T cell lymphocyte-associated antigen 4 have revo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Japanese journal of clinical oncology 2021-02, Vol.51 (2), p.167-172
Hauptverfasser:	Nishio, Hiroshi, Iwata, Takashi, Aoki, Daisuke
Format:	Artikel
Sprache:	eng
Schlagworte:	CTLA-4 Antigen - immunology Female Genital Neoplasms, Female - immunology Genital Neoplasms, Female - therapy Humans Immune Checkpoint Inhibitors - therapeutic use Immunosuppression Immunotherapy - trends Tumor Microenvironment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!